Virtual, global symposium for physicians (experienced clinicians and upcoming experts) who are engaged in getting a better understanding of the newest clinical updates and research discoveries with potential clinical application in the field of lysosomal storage disorders (LSDs).
The objectives of this symposium are to bring together RESEARCHERS and CLINICIANS with interest in the latest results from the field of science concerned with lysosomal pathology, pathobiochemical cascades in LSD, and advances in diagnosis and treatment!
Session 1: Disorders of Lysosomes and Lysosome-related Organelles in the Pathology of LSDs
Session 2: Pathologic Cascades and Identification of Novel Treatment Targets
Session 3: Pushing Toward Earlier Diagnosis and Individualized Treatment
Takeda is een op onderzoek gericht, wereldwijd opererend farmaceutisch bedrijf. De onderneming is commercieel actief in de therapeutische indicatiegebieden van stofwisselingsziekten, maag- en darmziekten, oncologie, hart- en vaatziekten, ziekten van het centrale zenuwstelsel, ontstekings- en immuunziekten, luchtwegaandoeningen en pijnbestrijding.